BioSpace News Archive

The study was in 55 patients who had an average of three previous treatment regimens. The results are promising enough that a Phase III trial is planned.

Sale reflects culmination of successful CDMO strategy initiated in 2015 and 59 percent 5-year CAGR of Masthercell under Orgenesis’ leadership

The U.S. Food and Drug Administration has a busy week planned for drug review. Here’s a look at this week’s schedule.

WindMIL Therapeutics and Providence Cancer Institute announced that the first patient has been identified in an investigator-sponsored study for the collection of bone marrow from patients with breast cancer.

The neurotech & AI company has the most sensitive tracker for eye motion on the cellular scale available today to predict neurological diseases in seconds

Verona Pharma plc announces publication of Phase 2b clinical trial results for ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease in the leading peer reviewed journal, Respiratory Research.

We summarize 2019 and note that: RaySearch continues to develop at a rapid pace.

Ascensia Diabetes Care, a leading global diabetes care company, announced that they will be continuing their support for this years’ Spare a Rose campaign.

Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 novel coronavirus (“2019-nCoV”) on its operations.

Bristol-Myers Squibb Company (NYSE:BMY) today announced the results of a robust multinational inflammatory bowel disease (IBD) survey conducted among patients and physicians, with findings revealing urgent and unmet needs in several key areas, including differences in expectations between patients and physicians that may impact disease management and treatment decisions